Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3025566	li-toxoabg	— (—)	19	20	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: prednisolone, methylprednisolone, prednisone

14.69

7.09

1.1

1.0

—

ILD medications: immunosuppressive drugs

19.18

6.97

1.1

1.0

—

ILD medications

11.89

6.53

1.1

1.0

—

Oral corticosteroids

10.37

5.90

1.1

1.0

—

Inflammatory bowel disease treatment related agents

8.52

5.31

1.1

1.0

—

Influenza and pneumonia

6.57

5.23

1.1

1.0

—

Malignant neoplasm

8.16

4.86

1.0

1.1

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

8.44

4.53

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

8.44

4.53

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

8.44

4.53

1.0

1.1

—

Second line medication for Crohn's disease

10.00

4.51

1.0

1.1

—

Bacterial infection, other or unspecified

12.63

4.30

1.1

1.0

—

Systemic connective tissue disorders

11.67

4.27

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

7.16

4.00

1.1

1.0

—

7.05

3.82

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7.05

3.82

1.1

1.0

—

L04AX Other immunosuppressants

8.75

3.77

1.0

1.1

—

Certain infectious and parasitic diseases

7.51

3.73

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5.75

3.48

1.1

1.0

—

Falls/tendency to fall

5.56

3.46

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

5.67

3.44

1.1

1.0

—

All pneumoniae

5.65

3.43

1.1

1.0

—

Any event in cancer register

5.93

3.42

1.0

1.1

—

COPD/asthma related infections

5.63

3.18

1.1

1.0

—

COPD/asthma/ILD related infections

5.63

3.18

1.1

1.0

—

Other bacterial diseases

5.53

3.06

1.1

1.0

—

Diseases of the eye and adnexa

7.01

2.89

1.1

1.0

—

Reimbursement for rheumatic diseases

6.65

2.86

1.0

1.1

—

Fall on same level

4.57

2.84

1.1

1.0

—

Irregular menses

6.95

2.82

1.0

—

Senile cataract

7.44

2.75

1.2

1.0

—

Used for control exclusion in common control thyroid runs

5.07

2.70

1.1

1.0

—

Visual disturbances and blindness

6.00

2.69

1.0

1.1

—

Fever of other and unknown origin

7.72

2.61

1.0

—

Pneumonia, organism unspecified

5.06

2.60

1.1

1.0

—

Rheumatoid arthritis, including avohilmo

7.14

2.55

1.0

1.1

—

Disorders of lens

6.31

2.54

1.2

1.0

—

Other and unspecified anaemias

6.91

2.49

1.2

1.0

—

Other anaemias

6.89

2.48

1.2

1.0

—

General symptoms and signs

4.45

2.46

1.1

1.0

—

Aplastic and other anaemias

6.77

2.45

1.2

1.0

—

Persons encountering health services for specific procedures and health care

4.13

2.43

1.1

1.0

—

Polyarthropathies

5.71

2.43

1.0

—

Other pulmonary diagnosis

5.01

2.39

1.1

1.0

—

Autoimmune diseases

4.09

2.32

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4.18

2.27

1.1

1.0

—

Polycystic ovarian syndrome, consortium definition

5.17

2.24

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

4.33

2.22

1.1

1.0

—

Abnormalities of breathing

5.09

2.21

1.2

1.0

—

Visual disturbances

5.00

2.07

1.0

1.1

—

Headache

5.22

2.07

1.0

—

Other heart diseases

5.50

2.04

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases

3.88

2.04

1.1

1.0

—

Codeine

3.85

2.02

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

4.33

1.97

1.2

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.63

1.94

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

3.54

1.92

1.1

1.0

—

Benign neoplasms

4.19

1.91

1.2

1.0

—

Autoimmune diseases related-to ILD

3.77

1.91

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

4.29

1.90

1.2

1.0

—

COPD differential diagnosis

4.29

1.90

1.2

1.0

—

ILD differential diagnosis

4.29

1.90

1.2

1.0

—

Dyspnoea

3.83

1.89

1.2

1.0

—

Codeine or tramadol medication

3.52

1.88

1.0

1.1

—

Other diseases of urinary system

3.75

1.76

1.0

1.1

—

Other disorders of urethra and urinary system

4.16

1.74

1.0

1.1

—

Pain in throat and chest

4.37

1.74

1.2

1.0

—

Other external causes of accidental injury

3.76

1.72

1.2

1.0

—

Other diseases of intestines

3.13

1.71

1.1

1.0

—

Hard cardiovascular diseases

4.01

1.65

1.2

1.0

—

Other diseases of upper respiratory tract

3.04

1.63

1.1

1.0

—

STROKE

3.85

1.62

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.23

1.62

1.2

1.0

—

Diseases of the respiratory system

4.18

1.61

1.2

1.0

—

Pain (limb, back, neck, head abdominally)

4.17

1.61

1.0

1.2

—

Neurotic, stress-related and somatoform disorders

3.05

1.53

1.0

1.1

—

Anxiety disorders

3.04

1.53

1.0

1.1

—

Dental caries 3, only avohilmo

3.65

1.47

1.0

1.1

—

Dental caries 3

3.65

1.47

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

3.63

1.46

1.2

1.0

—

Constipation

3.25

1.42

1.0

1.1

—

Metabolic disorders

2.87

1.41

1.2

1.0

—

Injuries to the head

2.79

1.39

1.0

1.1

—

Opioids

2.86

1.37

1.0

1.1

—

Finngen Rheumatological endpoints

3.17

1.34

1.2

1.0

—

Parasetamol

3.19

1.32

1.2

1.0

—

Arthropathies

3.18

1.32

1.2

1.0

—

Anxiety disorders, excluding more controls

3.01

1.31

1.0

1.1

—

Accidents

3.13

1.29

1.2

1.0

—

Benzodiazepine use

2.54

1.12

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

2.48

1.08

1.2

1.0

—

Type 2 diabetes, strict (exclude DM1)

2.49

1.07

1.2

1.0

—

Type 2 diabetes, definitions combined

2.49

1.07

1.2

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

2.35

0.79

1.2

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.35

0.79

1.2

1.0

—

Diseases of oral cavity, salivary glands and jaws

2.33

0.79

1.0

1.1

—

Dental caries 1 and operation codes

2.33

0.79

1.0

1.1

—

Type 2 diabetes

2.28

0.78

1.2

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

2.28

0.78

1.2

1.0

—

Symptoms and signs involving the digestive system and abdomen

2.28

0.78

1.0

1.1

—

Psychiatric diseases

2.28

0.78

1.0

1.1

—

Any mental disorder

2.28

0.78

1.0

1.1

—

Use of hypnotics and sedatives

2.22

0.77

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

2.21

0.76

1.2

1.0

—

Diabetes medication

2.17

0.76

1.2

1.0

—

Dental caries 3 and operation codes

2.14

0.75

1.0

1.1

—

Other heart diseases, wide

2.07

0.73

1.2

1.0

—

Diabetes, varying definitions

1.99

0.71

1.2

1.0

—

Diabetes mellitus

1.99

0.71

1.2

1.0

—

Diseases of the ear and mastoid process

1.95

0.69

1.2

1.0

—

1.89

0.68

1.2

1.0

—

Shoulder lesions

0.00

0.62

0.0

1.0

—

Exposure to other specified factors

0.00

0.60

0.0

1.1

—

Triptan medication for migraine, min. 3 purchases

0.00

0.40

0.0

1.1

—

Acute appendicitis, no complications

0.00

0.40

0.0

1.1

—

Recurrent or chronic depression

0.00

0.22

0.0

1.1

—

COPD related to multimorbidity

0.00

0.21

0.0

1.1

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.21

0.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.00

0.21

0.0

1.0

—

Primary gonarthrosis, bilateral

0.00

0.21

0.0

1.0

—

COPD, hospital admissions

0.00

0.21

0.0

1.1

—

COPD, early/later onset

0.00

0.21

0.0

1.1

—

Haemorrhage in early pregnancy

0.00

0.21

0.0

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

0.00

0.21

0.0

1.1

—

Vasomotor and allergic rhinitis

0.00

0.21

0.0

1.0

—

Pre-eclampsia or poor fetal growth

0.00

0.21

0.0

1.0

—

Hypertrophy of breast in women and men

0.00

0.21

0.0

1.1

—

Endometriosis ASRM stages 3,4

0.00

0.21

0.0

1.0

—

Injuries to the thorax

0.00

0.21

0.0

1.1

—

Preterm labour and delivery

0.00

0.21

0.0

1.0

—

Obesity, other/unspecified

0.00

0.21

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.00

0.21

0.0

1.1

—

Extrapyramidal and movement disorders

0.00

0.21

0.0

1.1

—

In situ neoplasms

0.00

0.21

0.0

1.1

—

Keratitis

0.00

0.21

0.0

1.1

—

Papulosquamous disorders

0.00

0.21

0.0

1.1

—

Other headache syndromes

0.00

0.21

0.0

1.0

—

Persons with potential health hazards related to communicable diseases

0.00

0.21

0.0

1.1

—

Inguinal hernia

0.00

0.21

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.00

0.21

0.0

1.1

—

Other arrhythmias

0.00

0.21

0.0

1.0

—

Glaucoma

0.00

0.21

0.0

1.1

—

Urticaria

0.00

0.21

0.0

1.1

—

Urticaria and erythema

0.00

0.21

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.00

0.21

0.0

1.1

—

Intracranial injury

0.00

0.21

0.0

1.1

—

Presence of other functional implants

0.00

0.21

0.0

1.0

—

Contraceptive management

0.00

0.20

0.0

1.1

—

Glucosamine medication

0.00

0.20

0.0

1.1

—

Malignant neoplasm of skin

0.00

0.20

0.0

1.1

—

Disorders of breast

0.00

0.20

0.0

1.0

—

Rotator cuff syndrome

0.00

0.20

0.0

1.0

—

Other and unspecified dermatitis

0.00

0.20

0.0

1.1

—

Infections with a predominantly sexual mode of transmission

0.00

0.0

1.1

—

Thyrotoxicosis with diffuse goitre

0.00

0.0

1.2

—

All dysplastic lesions of the cervix uteri

0.00

0.0

1.0

—

Adverse effects, not elsewhere classified

0.00

0.0

1.2

—

Cardiodefibrillation

0.00

0.0

1.1

—

Other gastritis (incl. Duodenitis)

0.00

0.0

1.0

—

Superficial injury of wrist and hand

0.00

0.0

1.1

—

Acute and subacute iridocyclitis

0.00

0.0

1.2

—

Other hearing loss

0.00

0.0

1.0

—

Spondylolisthesis/Spondylolysis

0.00

0.0

1.1

—

Other and unspecified iron deficiency

0.00

0.0

1.1

—

Other and unspecified tonsillitis

0.00

0.0

1.1

—

Primary open-angle glaucoma

0.00

0.0

1.1

—

Long labour

0.00

0.0

1.0

—

D07AA Corticosteroids, weak (group I)

0.00

0.0

1.2

—

Benign mammary dysplasia

0.00

0.0

1.0

—

Suppurative and unspecified otitis media

0.00

0.0

1.1

—

Colectomy operation

0.00

0.0

1.2

—

Other chronic obstructive pulmonary disease

0.00

0.0

1.0

—

Contact with and exposure to communicable diseases

0.00

0.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.0

1.1

—

Conduction disorders

0.00

0.0

1.0

—

Aneurysms, operations, SAH

0.00

0.0

1.2

—

Thyrotoxicosis, other and/or unspecified

0.00

0.0

1.1

—

Other/unspecified dorsalgia

0.00

0.0

1.1

—

Early onset COPD

0.00

0.0

1.2

—

COPD, hospital admission 2, with asthma infections

0.00

0.0

1.1

—

Other disorders of the genitourinary system

0.00

0.0

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

0.0

1.1

—

Retinal breaks without detachment

0.00

0.0

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.0

1.0

—

Abnormalities of forces of labour

0.00

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.0

1.0

—

Retention of urine

0.00

0.0

1.2

—

Cervical disc disorders

0.00

0.0

1.1

—

Suicide or other Intentional self-harm

0.00

0.0

1.1

—

Restless leg syndrome

0.00

0.0

1.2

—

Unspecific neurodegenerative disorder

0.00

0.0

1.2

—

Unstable angina pectoris

0.00

0.0

1.0

—

COPD

0.00

0.0

1.0

—

Noninfectious colitis NAS

0.00

0.0

1.2

—

Primary open-angle glaucoma, strict

0.00

0.0

1.1

—

Benign neoplasm: Sigmoid colon

0.00

0.0

1.2

—

Migraine without aura

0.00

0.0

1.0

—

Actinic keratosis

0.00

0.0

1.1

—

Internal derangement of knee

0.00

0.0

1.0

—

Primary coxarthrosis, bilateral

0.00

0.0

1.1

—

Blepharochalasis

0.00

0.0

1.2

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.0

1.2

—

Other female pelvic inflammatory diseases

0.00

0.0

1.0

—

Fracture of rib(s), sternum and thoracic spine

0.00

0.0

1.2

—

Other and unspecified urticaria

0.00

0.0

1.1

—

Allergic rhinitis

0.00

0.0

1.1

—

Glaucoma suspect

0.00

0.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.0

1.2

—

Non-ischemic cardiomyopathy

0.00

0.0

1.0

—

Diseases of male genital organs

0.00

0.0

1.2

—

DVT of lower extremities

0.00

0.0

1.2

—

Malignant neoplasm of breast, HER-negative

0.00

0.0

1.0

—

Ganglion

0.00

0.0

1.0

—

Schizophrenia or delusion, excluding more controls

0.00

0.0

1.1

—

Radiculopathy

0.00

0.0

1.2

—

Hypertrophy of breast

0.00

0.0

1.0

—

Allergic contact dermatitis

0.00

0.0

1.1

—

Postpartum hemorraghe, all women as controls

0.00

0.0

1.0

—

Dementia, including avohilmo

0.00

0.0

1.2

—

Psoriasis

0.00

0.0

1.1

—

Dementia

0.00

0.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.0

1.2

—

Acute suppurative otitis media

0.00

0.0

1.2

—

Psoriasis vulgaris

0.00

0.0

1.2

—

Trochanteric bursitis

0.00

0.0

1.0

—

Seborrhoeic keratosis

0.00

0.0

1.2

—

Soft tissue disorders related to use, overuse and pressure

0.00

0.0

1.0

—

Faecal incontinence

0.00

0.0

1.2

—

Other disorders of breast

0.00

0.0

1.0

—

Nausea and vomiting

0.00

0.0

1.1

—

Pacemaker

0.00

0.0

1.2

—

Polyuria

0.00

0.0

1.2

—

Thyrotoxicosis

0.00

0.0

1.1

—

Superficial injury of lower leg

0.00

0.0

1.1

—

Puerperal sepsis

0.00

0.0

1.0

—

Pre-eclampsia or eclampsia

0.00

0.0

1.0

—

Effects of foreign body entering through natural orifice

0.00

0.0

1.2

—

Type 1 diabetes, wide definition

0.00

0.0

1.0

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.0

1.0

—

Sub-endpoint used in defining T1D endpoints

0.00

0.0

1.2

—

Striking against or struck by other objects

0.00

0.0

1.1

—

Leisure time condition

0.00

0.0

1.2

—

Presence of cardiac and vascular implants and grafts

0.00

0.0

1.0

—

Postpartum hemorraghe, parous women as controls

0.00

0.0

1.0

—

In situ neoplasms

0.00

0.0

1.2

—

Otitis externa

0.00

0.0

1.2

—

Monoamine oxidase A inhibitors

0.00

0.0

1.2

—

Maternal care for other conditions predominantly related to pregnancy

0.00

0.0

1.0

—

Metatarsalgia

0.00

0.0

1.0

—

Deforming dorsopathies

0.00

0.0

1.1

—

Other and unspecified effects of external causes

0.00

0.0

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.0

1.2

—

0.00

0.0

1.1

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.0

1.0

—

Direct fill therapy

0.00

0.0

1.2

—

Cervicalgia

0.00

0.0

1.1

—

Diseases of external ear

0.00

0.0

1.1

—

Lichen planus, including avohilmo

0.00

0.0

1.1

—

Lichen planus

0.00

0.0

1.2

—

Somatoform disorder

0.00

0.0

1.2

—

Conjunctivitis (acute, non atopic)

0.00

0.0

1.1

—

Retained placenta and membranes, without haemorrhage

0.00

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

0.00

0.0

1.1

—

Pruritus

0.00

0.0

1.2

—

Type 1 diabetes

0.00

0.0

1.0

—

Schizophrenia or delusion

0.00

0.0

1.1

—

Other diseases of anus and rectum

0.00

0.0

1.0

—

Injuries to the neck

0.00

0.0

1.2

—

Any dementia

0.00

0.0

1.2

—

Postpartum haemorrhage

0.00

0.0

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

0.0

1.1

—

Unspecified lump in breast

0.00

0.0

1.0

—

Diseases of salivary glands

0.00

0.0

1.2

—

Cervicocranial syndrome

0.00

0.0

1.2

—

Adhesive capsulitis of shoulder

0.00

0.0

1.0

—

Benign leiomyoma with endometriosis

0.00

0.0

1.0

—

Embedded and impacted teeth

0.00

0.0

1.2

—

Bacterial intestinal infections, IBD co-morbidities

0.00

0.0

1.2

—

Other noninfective gastroenteritis and colitis

0.00

0.0

1.2

—

HSIL lesion of the cervix uteri

0.00

0.0

1.0

—

Cervicobrachial syndrome

0.00

0.0

1.1

—

Specific personality disorders

0.00

0.0

1.1

—

Other disorders of veins

0.00

0.0

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.00

0.0

1.0

—

Rheumatism, unspecified

0.00

0.0

1.0

—

Corneal ulcer

0.00

0.0

1.2

—

Pollen allergy

0.00

0.0

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

0.00

0.0

1.2

—

Other enthesopathies

0.00

0.0

1.0

—

Exclusions for E4_PCOS_BROAD

0.00

0.0

1.2

—

Impingement syndrome of shoulder

0.00

0.0

1.0

—

Myalgia

0.00

0.0

1.0

—

Endometriosis ASRM stages 1,2

0.00

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.0

1.0

—

Benign neoplasm of breast

0.00

0.0

1.0

—

Benign neoplasm: Rectum

0.00

0.0

1.2

—

Migraine with aura and triptan purchases

0.00

0.0

1.2

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.0

1.1

—

Other skin changes

0.00

0.0

1.2

—

Enthesopathies of lower limb, excluding foot

0.00

0.0

1.1

—

Lateral epicondylitis

0.00

0.0

1.0

—

Meniscus derangement

0.00

0.0

1.0

—

Pre-eclampsia

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS